Swedish drug discovery and development firm Biolipox AB raised €21 million in a second-round financing led by the Paris office of Apax Partners. (BioWorld International)

U.S. Officials Step Up Threats Over European Ban On GM Crops

By Peter O'Donnell

Wednesday, January 22, 2003

Buy Reprint

No Abstract

Future Drugs Could Disrupt Protein Biosynthesis In Cancer

By Sharon Kingman

Wednesday, January 22, 2003

Buy Reprint

No Abstract

Procognia Closes $4M Round, Acquires Sense Proteomic Ltd.

By Nuala Moran

Wednesday, January 22, 2003

Buy Reprint

No Abstract

BioWorld

Store

Others

BioWorld-International-2003-01-22

ReNeuron Shares Drop On Failed Phase II Trials Of Lead Product

Second Complication Arises In French Gene Therapy Trial

Xenova Paying $1M For Rights To Two Addiction Vaccines

Adebag Planning Biotechnology Cluster In Southeastern France

Cerep Collaborates With Pfizer On BioPrint Database, Software

Other News To Note

Biolipox Raises EUR21M To Fund Drug Discovery, Development

U.S. Officials Step Up Threats Over European Ban On GM Crops

Future Drugs Could Disrupt Protein Biosynthesis In Cancer

Procognia Closes $4M Round, Acquires Sense Proteomic Ltd.

Explore BioWorld.com

BioWorld

Store

Others

Login to Your Account

BioWorld

Store

Others

BioWorld-International-2003-01-22

Explore BioWorld.com

BioWorld

Store

Others